(Q40220381)

18 September 2017

title

The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study (English)

1 reference

diffuse large B-cell lymphoma

18 September 2017

1 reference

1 reference

based on heuristic

inferred from title

author

Nils Hermann Nilsson-Ehle

3

object named as

Herman Nilsson-Ehle

0 references

author name string

Sverker Hasselblom

1

1 reference

18 September 2017

Börje Ridell

2

1 reference

18 September 2017

Herman Nilsson-Ehle

3

1 reference

18 September 2017

Per-Ola Andersson

4

1 reference

18 September 2017

publication date

1 April 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

48

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

736-745

1 reference

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Non-Hodgkin's lymphoma in the Netherlands: results from a population-based registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Non-Hodgkin's lymphoma in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Prognosis of localized diffuse large B-cell lymphoma in younger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601187703

10.1080/10428190601187703

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference